Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis

Objectives To assess the prevalence of coronary heart disease (CHD) and chronic hypertension among patients with rheumatoid arthritis (RA) at the time of diagnosis, in comparison with age-specific and sex-specific non-RA subjects. Furthermore, the impacts of age at the onset of RA, as well as gender...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 72; no. 11; pp. 1826 - 1829
Main Authors Kerola, Anne M, Kerola, Tuomas, Kauppi, Markku J, Kautiainen, Hannu, Virta, Lauri J, Puolakka, Kari, Nieminen, Tuomo V M
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and European League Against Rheumatism 01.11.2013
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives To assess the prevalence of coronary heart disease (CHD) and chronic hypertension among patients with rheumatoid arthritis (RA) at the time of diagnosis, in comparison with age-specific and sex-specific non-RA subjects. Furthermore, the impacts of age at the onset of RA, as well as gender and the presence of rheumatoid factor (RF) on the risk of these comorbidities, were evaluated. Methods A cohort of 7209 RA patients diagnosed between January 2004 and December 2007 was identified, based on a Finnish nationwide register on special reimbursements for medication costs. The presence of CHD and chronic hypertension antedating the diagnosis of RA was identified from the same register. The prevalence of the cardiovascular comorbidities was compared with the general Finnish population, and a standardised rate ratio (SRR) for both these cardiovascular diseases was calculated. Results The risk of having CHD at RA diagnosis was slightly elevated, the SRR being 1.10 (95% CI 1.01 to 1.20). Younger age at the onset of RA seemed to be related with higher SRR for CHD. In a subset analysis, an increased prevalence of hypertension (SRR 1.19, 95% CI 1.10 to 1.30) and CHD (SRR 1.15, 95% CI 1.00 to 1.32) was apparent only among the RF negative RA cases. Conclusions The SRR for CHD is augmented in RA patients already at disease onset, and more pronouncedly in early onset RA. The findings highlight the importance of early prevention of atherosclerosis, regardless of RF status.
Bibliography:istex:B19DE594C62E9C607228FF658F7B01B04AA17792
local:annrheumdis;72/11/1826
href:annrheumdis-72-1826.pdf
PMID:23178207
Handling editor Tore K Kvien
ark:/67375/NVC-TKQ52G14-0
ArticleID:annrheumdis-2012-202398
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0003-4967
1468-2060
1468-2060
DOI:10.1136/annrheumdis-2012-202398